PFE vs. JNJ
Compare and contrast key facts about Pfizer Inc. (PFE) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PFE or JNJ.
Correlation
The correlation between PFE and JNJ is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
PFE vs. JNJ - Performance Comparison
Loading data...
Key characteristics
PFE:
-0.67
JNJ:
0.06
PFE:
-0.76
JNJ:
0.28
PFE:
0.91
JNJ:
1.04
PFE:
-0.26
JNJ:
0.12
PFE:
-1.12
JNJ:
0.32
PFE:
13.63%
JNJ:
6.52%
PFE:
24.48%
JNJ:
19.18%
PFE:
-58.96%
JNJ:
-52.60%
PFE:
-56.22%
JNJ:
-12.12%
Fundamentals
PFE:
$130.02B
JNJ:
$357.16B
PFE:
$1.33
JNJ:
$8.87
PFE:
16.56
JNJ:
16.50
PFE:
0.58
JNJ:
1.01
PFE:
2.08
JNJ:
4.00
PFE:
1.44
JNJ:
4.57
PFE:
$62.46B
JNJ:
$89.33B
PFE:
$42.09B
JNJ:
$61.01B
PFE:
$16.71B
JNJ:
$34.70B
Returns By Period
In the year-to-date period, PFE achieves a -11.75% return, which is significantly lower than JNJ's 4.28% return. Over the past 10 years, PFE has underperformed JNJ with an annualized return of 0.58%, while JNJ has yielded a comparatively higher 6.69% annualized return.
PFE
-11.75%
2.63%
-10.02%
-16.34%
-4.54%
0.58%
JNJ
4.28%
-2.61%
0.10%
1.14%
2.74%
6.69%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PFE vs. JNJ — Risk-Adjusted Performance Rank
PFE
JNJ
PFE vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
PFE vs. JNJ - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 7.52%, more than JNJ's 3.32% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 7.52% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
JNJ Johnson & Johnson | 3.32% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
PFE vs. JNJ - Drawdown Comparison
The maximum PFE drawdown since its inception was -58.96%, which is greater than JNJ's maximum drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for PFE and JNJ. For additional features, visit the drawdowns tool.
Loading data...
Volatility
PFE vs. JNJ - Volatility Comparison
Pfizer Inc. (PFE) has a higher volatility of 9.76% compared to Johnson & Johnson (JNJ) at 6.29%. This indicates that PFE's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
PFE vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PFE vs. JNJ - Profitability Comparison
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.